Tulsa, OK
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LMSARCOMA DIRECT RESEARCH FOUNDATION, founded in 2006, is a community nonprofit in the Science & Technology sector that reported $1.5M in total revenue in fiscal year 2024. Revenue surged 239% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.1M, a strong 77% operating margin.
To help find a cure for leiomyosarcoma by creating relationships with researchers and funding research that can lead to an effective treatment. To provide a forum for patients and care givers to share there experiences and to keep them informed of current studies.
The major program is to raise funds for the researching a cure for Leio0myosarcoma, a rare cancer. Very little money is invested in seed grants to discover methods that may lead to a cure. Research...
The major program is to raise funds for the researching a cure for Leio0myosarcoma, a rare cancer. Very little money is invested in seed grants to discover methods that may lead to a cure. Research is done by reputable organizations. LMSDR was able to fund 4 different research projects.
We have a Support Group Lifeline in order to serve newly diagnosed patients with information, support, guidance, and hope for treatment of their condition.
LMSDR sponsors conference where researchers can collaborate with each other and presents there work to LMS patients and caregivers.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,465,263 | $432,152 | +2.4% |
| Expenses | $330,368 | $230,111 | +0.4% |
| Net Income | $1,134,895 | $202,041 | +4.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Sharon Anderson | President | 10 |
Officer
Director
Key Emp
|
$0 | $0 | $0 |
| Denice Brice | Secretary | 2 |
Director
Key Emp
|
$0 | $0 | $0 |
| Howard Smith | Dir | 0 |
Key Emp
|
$0 | $0 | $0 |
| Edward Kurtz | Treasurer and V. President | 2 |
Key Emp
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $1,465,263 | $330,368 | $2,077,910 | $1,134,895 |
| 2023 | $432,152 | $230,111 | $915,978 | $202,041 |
| 2022 | $374,295 | $225,656 | $715,769 | $148,639 |
| 2021 | $293,809 | $273,734 | $567,130 | $20,075 |
Compare LMSARCOMA DIRECT RESEARCH FOUNDATION with other nonprofits in Oklahoma and across the country.